Anti- @entity375 cerevisiae (ASCA) and anti-neutrophil cytoplasmic (ANCA) antibodies are not increased in XXXX .

@entity1 @entity75 @entity31 @entity29 @entity12040 @entity375 @entity30
OBJECTIVES: @entity12040 ( @entity12040 ) may be associated with @entity29 ( @entity29 ). As there is such an overlap and since both diseases show @entity75 we reasoned similar biological pathways might be implicated in both conditions. Therefore, we investigated the prevalence of anti- @entity375 cerevisiae (ASCA) and anti-neutrophil cytoplasmic (ANCA) antibodies - serological markers for @entity29 -among @entity1 with @entity12040 . METHODS: Thirty-two @entity1 with @entity12040 , 21 with @entity30 ( @entity30 ), 17 with @entity31 ( @entity31 ) and 34 healthy controls were studied. Among 32 @entity1 with @entity12040 , 2 had @entity30 and one had @entity31 concomitantly. ASCA Ig A and Ig G antibodies were analyzed using a commercial ELISA kit. Immune fluorescence analysis (IFA) was used to assess the presence of ANCA antibodies. RESULTS: Only @entity1 with @entity30 had significantly higher levels of both ASCA Ig A and Ig G, compared to @entity1 with @entity12040 and healthy controls. Similarly, the frequency of ASCA positive @entity1 was higher only among @entity1 with @entity30 . ASCA Ig A and Ig G antibodies were found in 16 % (5/32) of @entity1 with @entity12040 . Among 3 @entity1 , in whom @entity12040 and @entity29 co-existed, only one (one with @entity30 ) had positive ASCA Ig G and A antibodies. The p-ANCA antibodies were present among @entity1 with @entity31 (35 %) and @entity30 (10 %). CONCLUSION: ASCA positivity in @entity12040 was similar to that found in @entity31 and healthy controls. No ANCA antibodies were detected among @entity1 with @entity12040 .
